Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.34 |
| ▸ | CPB2 | Q96IY4 | 5/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.33 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.33 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.33 |
| ▸ | GSR | P00390 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.31 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.31 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.31 |
| ▸ | NMT2 | O60551 | 1/20 | 0.31 |
| ▸ | NMT1 | P30419 | 1/20 | 0.31 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.31 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25462341 | 1.00 | FOLH1 (0.34) | FOLH1CPB2GABRR1SIRT6SIRT1 | |
| SCHEMBL13254054 | 1.00 | FOLH1 (0.34) | FOLH1CPB2GABRR1SIRT6SIRT1 | |
| SCHEMBL7604714 | 0.94 | FOLH1 (0.40) | FOLH1CPB2SIRT6SIRT1GSR | |
| SCHEMBL27250343 | 0.94 | FOLH1 (0.40) | FOLH1CPB2SIRT6SIRT1GSR | |
| SCHEMBL13573523 | 0.94 | FOLH1 (0.40) | FOLH1CPB2SIRT6SIRT1GSR | |
| SCHEMBL12762368 | 0.88 | GABRR1 (0.40) | GABRR1DPP7 | |
| SCHEMBL21166946 | 0.88 | GABRR1 (0.40) | GABRR1DPP7 | |
| SCHEMBL23191801 | 0.87 | NMT1 (0.40) | FOLH1CPB2SIRT6SIRT1DPP4 | |
| SCHEMBL21399748 | 0.86 | SIRT6 (0.36) | FOLH1CPB2GABRR1SIRT6SIRT1 | |
| SCHEMBL23330464 | 0.86 | FOLH1 (0.35) | FOLH1CPB2GABRR1SIRT6SIRT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11767354-B2 | Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors | JANSSEN PHARMACEUTICA NV (BE) | 2023-09-26 | — | — | US | disclosed |
| US-20230151074-A1 | MODULATORS OF G-PROTEIN COUPLED RECEPTORS | CARMOT THERAPEUTICS, INC. | 2023-05-18 | — | — | US | disclosed |
| US-20210163566-A1 | Antibody-Coupled Cyclic Peptide Tyrosine Tyrosine Compounds as Modulators of Neuropeptide Y Receptors | JANSSEN PHARMACEUTICA NV (BE) | 2021-06-03 | — | — | US | disclosed |
| US-10793601-B2 | Therapeutic spalt-like transcription factor 4 (SALL4) peptide | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2020-10-06 | — | — | US | disclosed |
| US-20190218253-A1 | Therapeutic SALL4 Peptide | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2019-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190218253-A1 | Therapeutic SALL4 Peptide | RBBP4, RBBP5, RB1 | FOLH1 2640/4885CPB2 1912/4885GABRR1 1991/4885 |
| US-10793601-B2 | Therapeutic spalt-like transcription factor 4 (SALL4) peptide | RBBP4, SALL4, RBBP5 | FOLH1 2155/4885CPB2 2463/4885GABRR1 1629/4885 |
| US-20210163566-A1 | Antibody-Coupled Cyclic Peptide Tyrosine Tyrosine Compounds as Modulators of Neuropeptide Y Receptors | NPY1R, NPY5R, NPY2R | FOLH1 911/4885CPB2 1246/4885GABRR1 230/4885 |
| US-11767354-B2 | Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors | NPY1R, NPY5R, NPY2R | FOLH1 911/4885CPB2 1246/4885GABRR1 230/4885 |
| US-20230151074-A1 | MODULATORS OF G-PROTEIN COUPLED RECEPTORS | GIPR, GLP1R, GCGR | FOLH1 2850/4885CPB2 3557/4885GABRR1 178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.